- ----------------------------------------------------------------------------
- ----------------------------------------------------------------------------

                      SECURITIES AND EXCHANGE COMMISSION 
                             Washington, DC 20549 
                              -----------------

                                 FORM 10-K/A 


            [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                  SECURITIES EXCHANGE ACT OF 1934 [FEE REQUIRED] 

                   For the fiscal year ended December 31, 1994 

                                     OR 

          [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
                SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED] 

                        Commission file number 0-15160 

                     ADVANCED TECHNOLOGY LABORATORIES, INC. 
             (Exact name of registrant as specified in its charter) 
                              ----------------

                Delaware                        91-1353386
   (State or other jurisdiction of             (I.R.S. Employer
    incorporation or organization)            Identification No.)

     22100 Bothell-Everett Highway 
             P.O. Box 3003 
          Bothell, Washington	                 98041-3003
 (Address of principal executive offices)       (Zip Code)


     Registrant's telephone number, including area code: (206) 487-7000 
     Securities registered pursuant to Section 12(b) of the Act: None. 
         Securities registered pursuant to Section 12(g) of the Act: 

                   Common Stock, par value $0.01 per share 
                             (Title of Class) 
                             ----------------


Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports) and (2) has been subject to 
such filing requirements for the past 90 days. Yes [x]   No [ ]       

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 
of Regulation S-K is not contained herein, and will not be contained, to the 
best of registrants' knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to 
this Form 10-K. [  ]

On February 24, 1995, the aggregate market value of the voting stock held by 
non affiliates of the registrant was $166,399,957 based upon the closing sale
price of $14.75 per share on the Nasdaq National Market on such date. 

Number of shares of Common Stock, $0.01 par value per share, of the 
registrant outstanding as of February 24, 1994: 13,344,783. 


	   Documents Incorporated by Reference                 Part
- ------------------------------------------------     ---------------------
                                                     	
Annual Report to Shareholders for the fiscal         Part II (Items 6-8)
year December 31, 1994                               Part IV (Item 14)	
Proxy Statement for the 1995 Annual General          Part III (Items 10-13)
Meeting of Shareholders

                         Exhibit Index is on page 22 
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------

                             SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.

                                    ADVANCED TECHNOLOGY LABORATORIES, INC.
                                                (Registrant)


DATE:  November 22, 1995            BY:    /s/ Harvey N. Gillis
                                           ------------------------------
                                           Harvey N. Gillis
                                           Senior Vice President
                                           Finance and Administration
                                           and Chief Financial Officer